1 February 2018 - The February 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are three major new/revised listings for this month:

• Cetuximab (Erbitux) - new indication
  
• Laronidase (Aldurazyme) - new indication
  
• Epoprostenol sodium (Veletri) - restriction change
  

Read New Zealand Pharmaceutical Schedule update